Cargando…

Ras and autophagy in cancer development and therapy

Autophagy, a process of self-degradation and turnover of cellular components, plays a complex role in cancer. Evidence exists to show that autophagy may support tumor growth and cell survival, whereas it can also contribute to tumor suppression and have anti-survival characteristics in different cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmukler, Eran, Kloog, Yoel, Pinkas-Kramarski, Ronit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996671/ https://www.ncbi.nlm.nih.gov/pubmed/24583697

Ejemplares similares

Ras inhibition enhances autophagy, which partially protects cells from death
por: Schmukler, Eran, et al.
Publicado: (2013)

Continuous treatment with FTS confers resistance to apoptosis and affects autophagy
por: Schmukler, Eran, et al.
Publicado: (2017)

APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes
por: Eran, Schmukler, et al.
Publicado: (2021)

Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death
por: Schmukler, Eran, et al.
Publicado: (2013)

Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
por: Schmukler, Eran, et al.
Publicado: (2012)

Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death
por: Schokoroy, Sari, et al.
Publicado: (2013)

Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
por: Goldshmit, Yona, et al.
Publicado: (2014)

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018)

Autophagy is induced and modulated by cholesterol depletion through transcription of autophagy-related genes and attenuation of flux
por: Shapira, Keren E., et al.
Publicado: (2021)

Autophagy in Parkinson’s Disease
por: Nechushtai, Lior, et al.
Publicado: (2023)

Altered mitochondrial dynamics and function in APOE4-expressing astrocytes
por: Schmukler, Eran, et al.
Publicado: (2020)

Inhibition of Ras GTPases prevents Collagen‐Induced Arthritis by Reducing the Generation of Pathogenic CD4(+) T Cells and the Hyposialylation of Autoantibodies
por: Zayoud, Morad, et al.
Publicado: (2020)

Identification of Nucleolin as New ErbB Receptors- Interacting Protein
por: Di Segni, Ayelet, et al.
Publicado: (2008)

Intercellular transfer of Ras: Implications for immunity
por: Goldstein, Itamar, et al.
Publicado: (2014)

Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells
por: Niv, Hagit, et al.
Publicado: (2002)

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)

Ras Inhibition Induces Insulin Sensitivity and Glucose Uptake
por: Mor, Adi, et al.
Publicado: (2011)

Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions
por: Farin, Keren, et al.
Publicado: (2009)

Intercellular Transfer of Oncogenic H-Ras at the Immunological Synapse
por: Rechavi, Oded, et al.
Publicado: (2007)

Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis
por: Barkan, Batya, et al.
Publicado: (2013)

Interplay Between HGF/SF–Met-Ras Signaling, Tumor Metabolism and Blood Flow as a Potential Target for Breast Cancer Therapy
por: Natan, Sari, et al.
Publicado: (2013)

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib
por: Faigenbaum, Raya, et al.
Publicado: (2013)

Ras inhibition by FTS attenuates brain tumor growth in mice directly and by enhancing reactivity of cytotoxic lymphocytes
por: Aizman, Elizabeta, et al.
Publicado: (2012)

Galectin-3 Mediates Cross-Talk between K-Ras and Let-7c Tumor Suppressor microRNA
por: Levy, Ran, et al.
Publicado: (2011)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
por: Tatli, Ozge, et al.
Publicado: (2021)

H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output
por: Rotblat, Barak, et al.
Publicado: (2010)

RAS Regulates the Transition from Naive to Primed Pluripotent Stem Cells
por: Altshuler, Anna, et al.
Publicado: (2018)

Targeting LIM kinase in cancer and neurofibromatosis
por: Rak, Roni, et al.
Publicado: (2014)

The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth
por: Hameiri-Grossman, Michal, et al.
Publicado: (2015)

Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer
por: Lee, Jennifer J., et al.
Publicado: (2021)

Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis via Targeting Pathogenic Antigen-Specific Th17-Type Cells
por: Zayoud, Morad, et al.
Publicado: (2017)

Emerging RAS-directed therapies for cancer
por: Conroy, Michael, et al.
Publicado: (2021)

Rasosomes originate from the Golgi to dispense Ras signals
por: Grunwald, A, et al.
Publicado: (2013)

Targeting RAS phosphorylation in cancer therapy: Mechanisms and modulators
por: Qiu, Yuran, et al.
Publicado: (2021)

Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors
por: Menachem, A, et al.
Publicado: (2015)

The role of autophagy in tumour development and cancer therapy
por: Rosenfeldt, Mathias T., et al.
Publicado: (2009)

Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy
por: Vitto, Veronica Angela Maria, et al.
Publicado: (2022)

Emerging strategies to target RAS signaling in human cancer therapy
por: Chen, Kun, et al.
Publicado: (2021)

RAS‐targeted cancer therapy: Advances in drugging specific mutations
por: Liu, Cen, et al.
Publicado: (2023)

Role of autophagy in K-RAS- and B-RAF-driven lung cancers
por: White, Eileen
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_imov5jr7gr4rgoaqa8bo09pfjn